| Name | Title | Contact Details |
|---|---|---|
John Loftis |
Chief Technology Officer | Profile |
Chris McLaurin |
Chief Technology Officer | Profile |
SciTec is a company that provides cutting edge advancements for defense, security, and civil affairs. Their team is committed to delivering advanced sensor systems, data processing algorithms, and testing equipment for defense, national security, and c...
Rural Wisconsin Health Cooperative is a Sauk City, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rural/Metro Corporation is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Rural/Metro Corporation is based in Scottsdale, AZ. You can find more information on Rural/Metro Corporation at www.rmetro.com
LEARN Behavioral is a national organization that specializes in providing tailored treatment programs for children and young adults with autism spectrum disorder (ASD). We use contemporary applied behavior analysis (ABA) therapy that is based on the un...
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.